Piper wallachii

Other Names

Chavica chuvya Miq.Chavica wallichii Miq.Chavica wallichii var. glabra Miq.Piper accrescens Van Heurck & Müll.Arg.Piper aurantiacum var. glabrum (Miq.) C.DC.Piper aurantiacum var. hupeense C.DC.Piper aurantiacum Wall.Piper aurantiacum Wall. ex C.DC.Piper caudilimbum C.DC.Piper chawya Buch.-Ham. ex Wall.Piper chuvya (Miq.) C.DC.Piper emeiense Y.C.TsengPiper flaviflorum C.DC.Piper henryci C.DC.Piper henryei C.DC.Piper ichangense C.DC.Piper martinii C.DC.Piper wallichii (Miq.) Hand.-Mazz.Piper wallichii var. hupeense (C.DC.) Hand.-Mazz.Poivrier de Wallichshi nan teng毛山蒟爬岩香爬崖香石南藤

Synopsis

Piper wallichii (Miq.) Hand.-Mazz.

1. Identity and Botanical Classification

1.1 Accepted Name, Synonymy, and Taxonomic Placement

The accepted botanical name of this species is Piper wallichii (Miq.) Hand.-Mazz. It belongs to the family Piperaceae, order Piperales. The basionym is Chavica wallichii Miq. (1843). The plant was originally described as Chavica wallichii Miq. in 1843; the widely cited synonym Piper aurantiacum Wall. ex DC. (1868) is regarded as illegitimate and superfluous. Additional synonyms recorded in the literature include Chavica chuvya Miq., Piper accrescens Van Heurck & Müll.Arg., Piper chuvya (Miq.) C.DC., Piper caudilimbum C.DC., Piper emeiense Y.C.Tseng, and Piper flaviflorum C.DC., among others, reflecting a complex nomenclatural history typical of the genus.

Piper, the genus to which this species belongs, is an economically and ecologically important genus in the family Piperaceae, containing approximately 1,000–2,000 species of shrubs, herbs, and lianas. Piper is one of the most diverse genera among basal lineages of angiosperms and is abundantly represented in the understory of tropical wet forests around the world.

1.2 Taxonomic Controversy: P. wallichii and the "Woody Pepper" Identity Dispute

A significant taxonomic controversy surrounds the identity of a spice plant from the Andaman Islands of India, locally known as Choi Jhaal or Woody Pepper. This species is popularly called Choi Jhaal or Woody Pepper in the Indian territory of the Andaman Islands; however, its botanical identity has remained debatable for quite some time, and recently, through DNA barcoding, the taxonomic confusion was resolved. The DNA barcoding approach employed two plastid barcode markers — the rbcL gene and the psbA-trnH spacer region — and the findings indicated that the correct botanical identity of the Andaman woody pepper is Piper pendulispicum. Considering those findings, the claim of earlier studies that identified Choi Jhal as P. wallichii has been found to be invalid, and certain earlier reports erroneously used the term "choijwal" as the common name of woody pepper instead of Choi Jhal.

Despite this, a substantial body of phytochemical and ethnobotanical literature published prior to the resolution of this confusion has been attributed to Piper wallichii. The Springer/Genetic Resources and Crop Evolution study that examined the Andaman plant (Latha & Bhat, 2020) treated it as P. wallichii at the time of publication. Additionally, the accepted species Piper wallichii itself — the focus of phytochemical investigations from China, Thailand, and India — is a confirmed, distinct taxon. This article addresses the established botanical entity Piper wallichii (Miq.) Hand.-Mazz. as documented in peer-reviewed chemical and pharmacological studies.

1.3 Geographic Distribution and Growth Habit

The native range of Piper wallichii extends from Nepal to central and southern China and Indochina. It is a liana and grows primarily in the temperate biome. It can be found in the northern, north-eastern, and south-western parts of Thailand, as well as China, Nepal, India, Bengal, and Indonesia. The plant is thus distributed across a broad swath of South, Southeast, and East Asia.

1.4 Common Names

Piper wallichii is known by several vernacular names across its range. In Thailand it is referred to as Cha Khan. In the Andaman Islands it was identified as a wild Piper vine from which woody stems are extracted, used to flavor curries. In Indian ethnobotanical literature, the species (or the plant previously assigned to it) has been called Choijwal or Choi Jhal. In China, the plant's stems are recorded in local medical usage without a unique widely standardized English common name.

1.5 Plant Morphology

As with other members of the Piperaceae family, P. wallichii is a woody climbing liana. The leaves of Piperaceae plants, which have a pungent flavor, grow singly, and numerous flowers, lacking sepals and petals, are crowded in dense spikes. The stems of P. wallichii are the primary plant part used in traditional medicine and phytochemical research. The species produces female spikes bearing fruits that have also been studied for their bioactive constituents.

2. Traditional and Historical Use

2.1 Chinese Traditional Medicine

Piper wallichii (Miq.) Hand.-Mazz. is a medicinal plant used widely in China for the treatment of rheumatoid arthritis, inflammatory diseases, cerebral infarction, and angina. This traditional application specifically concerns the stems, which have been used by local people in Chinese communities for these cardiovascular and inflammatory conditions. The stems have been used for the treatment of rheumatoid arthritis, inflammatory diseases, cerebral infarction, and angina by local people living in China.

2.2 Indian and Andaman Islands Traditions

A wild Piper vine growing in Andaman Islands was extracted from the wild for its woody stem with bark used for flavoring curries. The Karen tribe of North Andaman Island uses its leaf and stem for curing various ailments. The fruits of the plant are medicinally used in India to treat cold, fever, and cough, and as a uterine stimulant. The fruits are also believed to have cardiac and antibiotic properties.

Restrictions imposed by the Forest Department on extraction and sale of wild plants led to cultivation attempts in Little Andaman Island, and the plant's botany, chemical profile, ecology, ethnic uses, potential economic importance, propagation, and adaptability under cultivation were investigated.

2.3 Thai Traditional Medicine

In the Thai traditional system, the plant (Cha Khan) is recognized for multiple activities including hepatoprotective, antioxidant, vasodilator, antiarrhythmic, and anticancer effects, and the stems are medicinally used by local people in China to treat rheumatoid arthritis, inflammatory diseases, cerebral infarction, and angina. The fruits and leaves are also used medicinally against cold and cough. Furthermore, one study notes that P. wallichii is listed as a herbal material in Thai herbal references.

2.4 Culinary Use

Beyond strictly medicinal traditions, the plant's woody stems and bark have been used as a spice for flavoring curries in the Andaman Islands context, making it a dual-use plant with both culinary and medicinal traditions. The wild Piper vine was extracted from the wild for its woody stem with bark used for flavoring curries.

3. Phytochemistry: Key Constituents and Active Compounds

3.1 Overview of Compound Classes

Phytochemical investigation of Piper wallichii has revealed a chemically diverse array of secondary metabolites, spanning alkaloids, amides, aristolactams, lignans, neolignans, aromatic glycosides, phenolic acids, phenylpropanoids, biphenyls, and sterols. The bulk of this work has been carried out on stem material, with some studies addressing fruits and leaves.

3.2 Alkaloids and Amide Alkaloids

A phytochemical investigation of the stems and leaves of Piper wallichii led to the isolation of two new compounds — an aryl alkanone, piwalkanone (1), and a dioxoaporphine alkaloid, piwallidione (2) — together with nine known compounds: a dioxoaporphine alkaloid, cepharadione A (3); two aristolactams, piperolactam A (4) and stigmalactam (5); a piperidine, piperine (6); four isobutylamides, piperlonguminine (7), pellitorine (8), N-isobutyl-2E,4E-octadecadienamide (9), and guineensine (10); and a tyramine, N-trans-feruloyltyramine (11).

A subsequent study confirmed and expanded this profile. Four amides — piperine (1), pellitorine (2), piperiline (5), and N-trans-p-coumaroyltyramine (7) — and three aristolactams (piperolactams D, B, and A) were isolated from the methanol extract of Piper wallichii stems; piperiline and piperolactams B and D were obtained from this plant for the first time.

3.3 Aristolactams

Aristolactams represent a structurally and pharmacologically significant class within P. wallichii. Aristolactams, a large and important group of naturally occurring alkaloids possessing the phenanthrene lactam skeleton, have been frequently reported to possess biological properties such as anti-inflammatory activity and utility in treating arthritis, gout, and rheumatism, as well as anti-PAF (platelet-activating factor), antimycobacterial, and neuroprotective effects. In P. wallichii specifically, three aristolactams were isolated and their content in twelve batches of Piper wallichii were determined: cepharanone B (0.100–0.110 mg/g dry weight), aristolactam AII (0.198–0.208 mg/g dry weight), and aristolactam AIIIa (0.047–0.059 mg/g dry weight).

A study from Khon Kaen University isolated additional aristolactams from Thai-sourced material. Phytochemical analysis of the leaves of P. wallichii yielded four compounds: two aristolactams — stigmalactam (1) and piperolactam A (2) — together with two well-known sterols, β-sitosterol (3) and stigmasterol (4).

3.4 Lignans, Neolignans, and Aromatic Glycosides

The lignan and neolignan content of P. wallichii has been subject to particularly detailed study in relation to its antithrombotic traditional use. A new neolignan, piperwalliol A, and four new aromatic glycosides, piperwalliosides A–D, were isolated from the stems, along with 25 known compounds including 13 lignans, six aromatic glycosides, two phenylpropyl aldehydes, and four biphenyls. The lignan class in the genus Piper is noteworthy: at least 275 lignans have been discovered from the Piper genus, including traditional lignans, neolignans, oxyneolignans, norlignans, secolignans, and polyneolignans, and these lignans have been reported to show various pharmacological activities such as antimicrobial, anti-inflammatory, neuroprotective, antioxidative, anti-platelet aggregation, cytotoxic, and anti-parasitic activities.

3.5 Phenolic Acids and Other Phenolics

Studies on the stems of P. wallichii have identified a range of phenolic acids and related compounds. A study investigating bioactive constituents in the stem isolated 10 compounds whose structures were identified as 3,4-methylenedioxy-benzoic acid, vanillic acid, benzoic acid, N-p-coumaroyltyramine, futoenone, futoquinol, isofutoquinol A, 4-hydroxy-3,5-dimethoxy-benzoic acid, futoamide, and dihydropiperlonguminine.

3.6 Sterols

Sterols, as essential components of eukaryotic cell membranes playing an important role in regulating the physicochemical properties of cell membranes, have also been reported from P. wallichii. Specifically, β-sitosterol and stigmasterol have been identified from the leaves of Thai specimens.

3.7 Novel Species-Specific Compounds

Two compounds novel to science were first described from P. wallichii: piwalkanone (a new aryl alkanone) and piwallidione (a new dioxoaporphine alkaloid). Their structures were elucidated on the basis of spectroscopic evidence, including IR, 1H NMR, 13C NMR, and 2D NMR, and MS. Additionally, piperwalliol A (a new neolignan) and piperwalliosides A–D (four new aromatic glycosides) represent named compounds first isolated from this species.

4. Mechanisms of Action

4.1 Antithrombotic Mechanisms

The antithrombotic mechanism of P. wallichii has been partially elucidated through isolation and bioassay. Five known compounds showed in vitro antiplatelet aggregation activities, with (−)-syringaresinol being the most active, with an IC₅₀ value of 0.52 mM. In a zebrafish model, syringaresinol showed good in vivo antithrombotic effect at a value of 37% inhibition at a concentration of 30 μM, compared with the positive control aspirin, which showed an inhibitory value of 74% at a concentration of 125 μM. This study demonstrated that lignans, phenylpropanoids, and biphenyls found in Piper wallichii may be responsible for the antithrombotic effect of the plant.

The antiplatelet activity was tested by evaluating inhibitory effects on platelet aggregation induced by platelet-activating factor (PAF) in a rabbit blood model, with active compounds subsequently evaluated in the zebrafish in vivo model. Previous work showed that lignans and neolignans from Piper species had potential inhibitory activities on platelet aggregation.

4.2 Antioxidant Mechanisms

The antioxidant activities of ethanol, methanol, chloroform, ethyl acetate, and petroleum ether extracts from the fruit of Piper wallichii were investigated using different in vitro antioxidant assays; the methanol extract showed the most potent scavenging activity on DPPH, FRAP, ABTS, hydrogen peroxide, hydroxyl radical, and reducing power assays, with EC₅₀ values of 46.70 ± 0.85, 41.7 ± 0.74, 45.23 ± 2.02, 49.30 ± 1.15, 40.39 ± 1.92, and 50.21 ± 1.2 μg/mL, respectively. The methanol extract also showed the highest total phenolic content and total flavonoid content, followed by the chloroform extract.

The phenolic acids isolated from stem material contribute to this antioxidant activity via free-radical scavenging. Vanillic acid and 4-hydroxy-3,5-dimethoxy-benzoic acid showed scavenging activity against DPPH radical with ED₅₀ values of 224.33 μg/mL and 11.44 μg/mL, respectively. Furthermore, previous studies on P. wallichii showed that methanol extracts of its fruits and leaves possessed antioxidant activity; two phenolic compounds — vanillic acid and 4-hydroxy-3,5-dimethoxy-benzoic acid — and an amide derivative found in its stems displayed scavenging activity against the DPPH radical.

4.3 Antibacterial Mechanisms

Dioxoaporphine alkaloids appear to be the principal antibacterial constituents identified in P. wallichii. Compounds piwallidione (2) and cepharadione A (3) showed inhibitory activities against pathogenic bacteria, specifically Bacillus cereus, Bacillus subtilis, and Staphylococcus aureus. The aristolactam class also contributes to this profile: piperolactams D and A showed antibacterial activity against Gram-positive bacteria (B. subtilis and S. aureus) with MICs of between 500–1000 μM.

4.4 Anticancer / Cytotoxic Mechanisms

All test amide and aristolactam compounds were cytotoxic to breast cancer (MCF-7) cells, while the aristolactams were more toxic to colon cancer (Caco-2) cells than the amides; N-trans-p-coumaroyltyramine and piperolactam A were moderately cytotoxic to the doxorubicin-resistant MCF-7 subline (MCF-7/DOX). All compounds were non-toxic to normal human fibroblast (NIH/3T3) cells.

Separately, a study explored the effects of a P. wallichii extract on human tongue squamous cell carcinoma (Tca83) cells. That work studied the chemical constituents of Piper wallichii and explored the effects of the extractive on proliferation and telomerase activity of human tongue squamous cell carcinoma Tca83 cells and its anticancer mechanisms. Effects of different concentrations of the extractive on Tca-83 cell proliferation were detected by MTT assay, and changes in telomerase activity of Tca83 cells were determined by TRAP-ELISA.

5. Scientific Evidence by Area of Biological Activity

5.1 Antioxidant Activity

Evidence type: In vitro (laboratory); no human clinical trials identified.

The antioxidant activity of P. wallichii has been demonstrated across multiple assay systems using fruit, leaf, and stem extracts. The methanol extract of P. wallichii fruits showed potent scavenging activity across six in vitro antioxidant assays (DPPH, FRAP, ABTS, H₂O₂, hydroxyl radical, and reducing power), with EC₅₀ values ranging from approximately 40–50 μg/mL. Piperine isolated from the stems displayed DPPH radical scavenging activity with an IC₅₀ value of 94.51 ± 11.91 μM.

Strength of evidence: This evidence is entirely preliminary and in vitro. No animal studies or human clinical trials have been reported for the antioxidant application of this specific species. Results must be interpreted with caution given the methodological limitations inherent in cell-free radical-scavenging assays.

5.2 Antithrombotic / Antiplatelet Activity

Evidence type: In vitro (rabbit blood model) and in vivo (zebrafish model); no human clinical trials identified.

This is arguably the most mechanistically developed area of research for P. wallichii, directly supported by its traditional use in treating cerebral infarction and cardiovascular conditions in China. A new neolignan (piperwalliol A) and four new aromatic glycosides (piperwalliosides A–D) were isolated from the stems along with 25 known compounds including 13 lignans; five known compounds showed in vitro antiplatelet aggregation activities, with (−)-syringaresinol being the most active at IC₅₀ of 0.52 mM. In the zebrafish model, syringaresinol showed a good in vivo antithrombotic effect at 37% inhibition at 30 μM, compared to aspirin's 74% inhibition at 125 μM.

All compounds were tested for their inhibitory effects on platelet aggregation induced by platelet-activating factor (PAF) in rabbit blood model, from which the active ones were further evaluated for in vivo antithrombotic activity in the zebrafish model.

Strength of evidence: Preliminary — animal/invertebrate models only. The data provide mechanistic plausibility for the traditional cardiovascular applications but cannot be extrapolated to human efficacy without clinical trials, which have not been conducted.

5.3 Antibacterial Activity

Evidence type: In vitro (microbiological assays); no animal or human studies identified.

Two independent phytochemical investigations have demonstrated antibacterial activity of isolated compounds from P. wallichii. In the first, compounds piwallidione and cepharadione A showed inhibitory activities against pathogenic bacteria — Bacillus cereus, Bacillus subtilis, and Staphylococcus aureus. In the second, piperolactams D and A showed antibacterial activity against Gram-positive bacteria (B. subtilis and S. aureus) with MICs of between 500–1000 μM.

Strength of evidence: Weak to preliminary — in vitro antibacterial assays against limited strains. MIC values for the aristolactam compounds are relatively high, suggesting moderate potency at best under in vitro conditions. No translation to animal infection models or clinical application has been reported.

5.4 Cytotoxic / Anticancer Activity

Evidence type: In vitro (cancer cell line models); no animal or human studies identified.

Cytotoxicity has been assessed in breast cancer (MCF-7), colon cancer (Caco-2), drug-resistant breast cancer (MCF-7/DOX), and human tongue squamous cell carcinoma (Tca83) cell lines. All test amide and aristolactam compounds isolated from P. wallichii were cytotoxic to breast cancer (MCF-7) cells, while the aristolactams were more toxic to colon cancer (Caco-2) cells than the amides. Crucially, all compounds were non-toxic to normal human fibroblast (NIH/3T3) cells in the same study. The tongue carcinoma study employed MTT and TRAP-ELISA assays to assess both anti-proliferative and telomerase-inhibitory effects.

Strength of evidence: Preliminary — entirely in vitro. Cytotoxicity demonstrated in isolated cell lines does not predict in vivo efficacy or safety. No animal tumor model studies or human trials have been conducted.

5.5 Anti-Inflammatory Activity

Evidence type: Traditional use, supported by in vitro data; no clinical trials identified.

The plant's traditional application for rheumatoid arthritis and inflammatory diseases is the primary driver of interest in its anti-inflammatory potential. The plant possesses multiple documented activities including hepatoprotective, antioxidant, vasodilator, antiarrhythmic, and anticancer effects based on preclinical investigation. Aristolactam-class compounds isolated from the plant possess known anti-inflammatory properties in the broader literature: aristolactams, as a large group of naturally occurring alkaloids possessing the phenanthrene lactam skeleton, have been frequently reported with biological properties including anti-inflammatory activity and utility in treating arthritis, gout, and rheumatism.

Strength of evidence: Weak — based on traditional use and the pharmacological class of isolated constituents. No formal anti-inflammatory bioassay data specifically attributable to P. wallichii extracts or isolates (beyond the constituent-class level) have been identified in the peer-reviewed literature.

5.6 Hepatoprotective Activity

The plant has been associated with hepatoprotective activity in the Thai traditional and pharmacological literature, but no dedicated study specifically evaluating hepatoprotective effects of P. wallichii extracts through validated in vitro hepatocyte or in vivo animal models was identified in the peer-reviewed literature at the time of writing. The claim appears to originate from extrapolation based on the phytochemical profile of the plant.

Strength of evidence: Unverified by direct experimental evidence; stated as a claimed activity in secondary literature.

6. Body Systems and Health Areas of Association

Cardiovascular system: Traditional use for cerebral infarction and angina; lignan-mediated antiplatelet aggregation demonstrated in vitro and in zebrafish; historical vasodilator and antiarrhythmic associations.
Musculoskeletal / immune system: Traditional use for rheumatoid arthritis and inflammatory diseases; aristolactam constituents with known anti-inflammatory class effects.
Infectious disease (antibacterial): In vitro inhibitory activity of dioxoaporphine alkaloids and aristolactam isolates against Gram-positive bacteria (Bacillus spp., Staphylococcus aureus).
Oncology (in vitro only): Cytotoxic activity against MCF-7 (breast), Caco-2 (colon), doxorubicin-resistant MCF-7, and Tca83 (tongue squamous cell carcinoma) cancer cell lines.
Oxidative stress / general health: In vitro antioxidant activity across multiple assay systems in fruit and stem extracts.
Respiratory / cold and cough: Traditional use of fruits and leaves for cold and cough symptoms in Indian and Thai traditions.
Uterine stimulant (traditional): Fruits reported in Indian traditional medicine as a uterine stimulant.
Liver (hepatoprotective): Cited as a hepatoprotective plant in Thai references, without direct experimental confirmation identified in the reviewed literature.

7. Dosage Forms and Preparations

No standardized dosage forms, commercially regulated preparations, or human-trial dosages have been established for Piper wallichii. The following preparative contexts are documented in the scientific literature:

Crude plant material (traditional / culinary): Woody stems and bark of the plant are used in dried form for flavoring curries; leaves and stems are used by the Karen tribe in traditional medicine without a reported standardized preparation method.
Solvent extracts (research settings): Research studies have employed methanol, ethanol, chloroform, ethyl acetate, and petroleum ether extracts of the stems and fruits. In antioxidant studies, fruits at maturity were collected and dried under shade to obtain dry sample material, which was then powdered to 60 mesh size and extracted in petroleum ether, chloroform, ethyl acetate, methanol, and ethanol respectively.
Methanol extract for compound isolation: The methanolic extract of air-dried stems of Piper wallichii was separated and purified using various chromatographic methods, including semi-preparative HPLC.
Dried stem material for HPLC quantification: Three aristolactams were isolated from Piper wallichii and quantified by HPLC; their content ranges in twelve batches were 0.100–0.110 mg/g dry weight (cepharanone B), 0.198–0.208 mg/g dry weight (aristolactam AII), and 0.047–0.059 mg/g dry weight (aristolactam AIIIa).

No human clinical trial has reported a tested dose range for any preparation of Piper wallichii. All quantitative data above derive from research extraction procedures and quality-control analyses, not from therapeutic dosing protocols.

8. Safety Considerations

8.1 Aristolactam Content and Renal Cytotoxicity Concerns

The most significant safety concern identified for Piper wallichii in the peer-reviewed literature relates to its content of aristolactam alkaloids, which are structurally analogous to the well-characterized nephrotoxic and carcinogenic aristolochic acids.

The anti-proliferative effects of three aristolactams isolated from P. wallichii in HK-2 human renal tubular epithelial cells were determined by MTT assay and membrane damage was assessed by LDH release assay; results indicated that the test compounds showed time- and dose-dependent cytotoxicity in HK-2 cells, with IC₅₀ values in the order cepharanone B > aristolactam AII > aristolactam AIIIa.

The broader class concern is explicitly stated in the pharmacological literature: aristolactams are analogues of nephrotoxic aristolochic acids, in which the carboxyl group and nitro group of aristolochic acids form an amide ring by condensation; due to the high structural similarity between aristolochic acids and aristolactams, the safety of aristolactams and aristolactam-containing plants has been under constant scrutiny. As the most common nephrotoxic aristolochic acid metabolite, aristolactam I has been studied extensively and has exhibited nephrotoxicity both in vitro and in vivo.

The structural similarity between aristolactams and aristolochic acids raises constant concerns about the safety of aristolactam-containing plants. Natural aristolactams are distributed more extensively than aristolochic acids, leading to a higher risk of aristolactam exposure in daily consumption.

It is important to note that the toxicological data on individual aristolactam isomers are variable and cell-line dependent. Some studies found that aristolactam I did not cause renal abnormality in certain animal models, with AA IVa and aristolactam I causing no renal abnormality indicated by blood chemistry or histologic change in that experimental system. Nonetheless, the in vitro evidence for renal cell cytotoxicity from P. wallichii-derived aristolactams represents a substantiated concern that warrants further investigation before any human use could be considered established as safe.

8.2 Normal Cell Toxicity of Isolated Compounds

In the cytotoxicity study evaluating amide and aristolactam isolates, all test compounds were non-toxic to normal human fibroblast (NIH/3T3) cells. This finding provides limited reassurance but cannot substitute for broader toxicological evaluation including renal cell lines, as demonstrated by the separate renal cytotoxicity study above.

8.3 Uterine Stimulant Activity

The fruits of P. wallichii are medicinally recorded in India as a uterine stimulant. This reported uterotonic effect raises a theoretical concern for use during pregnancy, consistent with the wider pattern of uterine-active Piper species. However, no specific pharmacological study confirming this property in P. wallichii was identified in the reviewed literature.

8.4 Antiplatelet Activity and Drug Interactions

The documented antiplatelet aggregation activity of lignan isolates from P. wallichii — particularly the in vitro and zebrafish in vivo data for (−)-syringaresinol — raises a theoretical concern for additive or potentiating effects with anticoagulant or antiplatelet pharmaceutical drugs if the plant is consumed in significant quantities. However, no interaction studies in humans or animals have been conducted to define this risk.

8.5 Absence of Regulatory Status

No regulatory body — including the US NIH Office of Dietary Supplements, the European Medicines Agency (EMA), the European Food Safety Authority (EFSA), WHO, or ESCOP — has published a formal monograph, safety assessment, or approved therapeutic application for Piper wallichii. It is not listed in the German Commission E positive monographs. Its safety profile in humans has not been established through clinical evaluation.

9. Research Gaps and Evidence Summary

The totality of evidence for Piper wallichii as a dietary supplement or natural medicine ingredient is at a very early, exploratory stage. All pharmacological data are derived from in vitro cell and biochemical assays, or from zebrafish and rabbit blood models. No randomized controlled trials, observational human studies, or systematic reviews of clinical evidence for any therapeutic application have been identified. The plant's traditional uses — primarily documented from Chinese local medical practice and the Karen community of the Andaman Islands — provide ethnopharmacological context and hypothesis generation, but cannot be equated with clinical evidence of efficacy or safety.

Specifically documented areas requiring further research include: (1) dedicated anti-inflammatory bioassay studies to substantiate the joint-disease traditional use; (2) rigorous in vivo studies translating the antithrombotic findings from cell and zebrafish models to mammalian systems; (3) comprehensive toxicological evaluation of aristolactam-containing fractions in renal cell models and in vivo; (4) resolution of the ongoing taxonomic uncertainty between Piper wallichii and Piper pendulispicum as it pertains to ethnobotanical records; and (5) characterization of bioavailability and metabolic fate of key isolates in mammalian systems.

References

Health Conditions

Health conditions that Piper wallachii may help support.

No conditions available.

Body Systems

Body systems that Piper wallachii may help support.

No body systems available.